Title
Etiologies and manifestations of persistent diarrhea in adults with HIV-1 infection: A case-control study in Lima, Peru
Date Issued
01 January 2005
Access level
metadata only access
Resource Type
journal article
Publisher(s)
Oxford University Press
Abstract
Objective. We sought to determine the etiologies, manifestations, and risk factors for persistent (&7 days) diarrhea in human immunodeficiency virus type 1 (HIV-1)-infected persons in Peru. Design. The present study is a case-control study of 147 HIV-1-infected case subjects with persistent diarrhea and 147 HIV-1-infected control subjects without diarrhea. Methods. We obtained clinical, demographic, and exposure data, CD4 lymphocyte counts, and stool samples for detection of enteric parasitic and bacterial pathogens and rotavirus. Results: One or more enteric pathogen was identified in 55% of case subjects and 21% of control subjects (odds ratio adjusted for CD4 lymphocyte count, 3.8; 95% confidence interval, 2.2-6.5). The median CD4 lymphocyte count was highest with pathogen-free diarrhea and lowest with Cryptosporidium infection. Cryptosporidium species (the most frequent pathogen), Giardia lamblia, Aeromonas species, Campylobacter species, and rotavirus were all significantly associated with diarrhea. Bacterial pathogens were significantly associated with G. lamblia and rotavirus infection. Of the bacterial pathogens (Aeromonas, Campylobacter, Salmonella, and Vibrio species and enterotoxigenic Escherichia coli), only 24% were susceptible to cotrimoxazole, whereas 90% were susceptible to ciprofloxacin. In no case did the sensitivity or positive predictive value of specific clinical and laboratory findings for curable enteric infections exceed 50%. Conclusions. Several enteric pathogens were associated with diarrhea in HIV-1-infected case subjects in Peru, especially among those who were heterosexual. Clinical findings were poor predictors of detectable microbial etiology. The guidelines for initial management of chronic diarrhea with sulfamethoxazole-trimethoprim in HIV-1-infected persons require revision, at least in settings where prophylaxis with this agent is common.
Start page
11
End page
19
Volume
191
Issue
1
Language
English
OCDE Knowledge area
Inmunología Patología Enfermedades infecciosas
Scopus EID
2-s2.0-19944373738
PubMed ID
Source
Journal of Infectious Diseases
ISSN of the container
00221899
Source funding
Centers for Disease Control and Prevention
Sponsor(s)
Programa Internacional de Investigación y Formación sobre el SIDA Fundación Anderson de la Facultad de Medicina de la Universidad de Washington Centros de Control y Prevención de Enfermedades Centro Internacional Fogarty Universidad de Washington Centro de Investigación del SIDA, Universidad de Washington
Sources of information: Directorio de Producción Científica Scopus